NCT07022483 2026-02-04Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerDaiichi SankyoPhase 3 Recruiting710 enrolled
NCT05524389 2022-11-23Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy DecisionsPeking Union Medical College HospitalPhase 3 Not yet recruiting624 enrolled